DTP-HepB vaccine
| Combination of | |
|---|---|
Intramuscular injection | |
| ATC code | |
| Identifiers | |
| CAS Number | |
DTP-HepB vaccine is a
pertussis, and hepatitis B.[1]
A branded formulation, Tritanrix-HepB manufactured by
GlaxoSmithKline, was granted marketing approval in the EU in 1996. Marketing approval lapsed in 2014.[2]
A review conducted in 2012 concluded that there was insufficient evidence to determine differences in safety and efficacy between DTP-HepB vaccine and
DTP-HepB-Hib vaccine.[3]
References
- ISBN 9789241546515. Retrieved 15 July 2018.
- ^ "Tritanrix HepB". European Medicines Agency. Archived from the original on 15 July 2018. Retrieved 14 July 2018.
- PMID 22513932.
